{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:07:24Z","timestamp":1778288844048,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","award":["EGY 1191187"],"award-info":[{"award-number":["EGY 1191187"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["471,614,207"],"award-info":[{"award-number":["471,614,207"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["469954457"],"award-info":[{"award-number":["469954457"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107887","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T10:56:29Z","timestamp":1728730589000},"page":"107887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders"],"prefix":"10.1016","volume":"153","author":[{"given":"Hany S.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebatian","family":"Hilscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Schutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunquan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107887_b0005","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00018-019-03098-1","article-title":"Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy","volume":"76","author":"Patra","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2024.107887_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications \u2014 cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bioorg.2024.107887_b0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/cb500235n","article-title":"Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes","volume":"9","author":"Becher","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2024.107887_b0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/ph7060634","article-title":"Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1\/HDAC3 Inhibitors","volume":"7","author":"Thomas","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2024.107887_b0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","article-title":"HDAC8: a multifaceted target for therapeutic interventions","volume":"36","author":"Chakrabarti","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2024.107887_b0030","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1200\/JCO.2022.40.16_suppl.11553","article-title":"A phase 1 dose-escalation\/expansion clinical trial of mocetinostat in combination with vinorelbine in adolescents and young adults with refractory and\/or recurrent rhabdomyosarcoma: Interim results","volume":"40","author":"Federman","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2024.107887_b0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11523-021-00823-4","article-title":"Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer","volume":"16","author":"Wang","year":"2021","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bioorg.2024.107887_b0040","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2008.9","article-title":"A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas","volume":"22","author":"Balasubramanian","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2024.107887_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2024.107887_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115839","article-title":"Targeted protein degradation in drug development: Recent advances and future challenges","volume":"261","author":"Song","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.bioorg.2024.107887_b0060","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.3390\/molecules26237241","article-title":"Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands","volume":"26","author":"Lu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107887_b0065","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1039\/D0CC01485K","article-title":"PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes","volume":"56","author":"Smalley","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107887_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acs.biochem.2c00288","article-title":"Comprehensive Transcriptomic Analysis of Novel Class I HDAC Proteolysis Targeting Chimeras","volume":"62","author":"Baker","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107887_b0075","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/acs.jmedchem.1c02179","article-title":"Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1\/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells","volume":"65","author":"Smalley","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0080","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1039\/D0CC03243C","article-title":"Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs","volume":"56","author":"Xiao","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107887_b0085","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00761","article-title":"Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8","author":"Xiao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0090","doi-asserted-by":"crossref","first-page":"14016","DOI":"10.1021\/acs.jmedchem.4c00836","article-title":"Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1039\/D3CB00105A","article-title":"PROTAC chemical probes for histone deacetylase enzymes","volume":"4","author":"Patel","year":"2023","journal-title":"RSC Chemical Biology"},{"key":"10.1016\/j.bioorg.2024.107887_b0100","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1039\/D2CC00272H","article-title":"Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera","volume":"58","author":"Chotitumnavee","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2024.107887_b0105","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1021\/acs.jmedchem.2c00739","article-title":"Structure-Based Discovery of Selective Histone Deacetylase 8 Degraders with Potent Anticancer Activity","volume":"66","author":"Huang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114544","article-title":"Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8","volume":"239","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0115","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.3390\/ijms23147535","article-title":"Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity","volume":"23","author":"Darwish","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107887_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106546","article-title":"Discovery of highly potent HDAC8 PROTACs with anti-tumor activity","volume":"136","author":"Zhao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/ijms23010369","article-title":"Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity","volume":"23","author":"Ibrahim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107887_b0130","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/molecules27082526","article-title":"Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors","volume":"27","author":"B\u00fclb\u00fcl","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107887_b0135","series-title":"HDAC\/HAT Function Assessment and Inhibitor Development: Methods and Protocols","first-page":"145","article-title":"Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1\u20133 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell Lines","author":"Abdelsalam","year":"2023"},{"key":"10.1016\/j.bioorg.2024.107887_b0140","doi-asserted-by":"crossref","first-page":"2300536","DOI":"10.1002\/ardp.202300536","article-title":"Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells","volume":"357","author":"Abdelsalam","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107887_b0145","article-title":"Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells","author":"Fischer","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2024.107887_b0150","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41375-023-02036-2","article-title":"Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3","volume":"37","author":"Zeyn","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2024.107887_b0155","doi-asserted-by":"crossref","first-page":"12831","DOI":"10.1021\/acs.jmedchem.1c00882","article-title":"Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer","volume":"64","author":"Han","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0160","doi-asserted-by":"crossref","first-page":"2100467","DOI":"10.1002\/ardp.202100467","article-title":"Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models","volume":"355","author":"Gockel","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2024.107887_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113328","article-title":"Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy\/lysosome degradation systems","volume":"218","author":"Qu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0170","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/acs.jmedchem.0c01897","article-title":"Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91","volume":"64","author":"Hanafi","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116167","article-title":"Design, synthesis, and biological characterization of proteolysis targeting chimera (PROTACs) for the ataxia telangiectasia and RAD3-related (ATR) kinase","volume":"267","author":"Alfayomy","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors\u2014What Some May Have Forgotten or Would Rather Forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107887_b0185","doi-asserted-by":"crossref","first-page":"26663","DOI":"10.1002\/anie.202108848","article-title":"Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs","volume":"60","author":"Min","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2024.107887_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112338","article-title":"Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6\/8 and bromodomain BRPF1","volume":"200","author":"Ghazy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107887_b0195","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/cmdc.201200193","article-title":"Design, Synthesis, and Biological Evaluation of 2-Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors","volume":"7","author":"Stolfa","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107887_b0200","doi-asserted-by":"crossref","first-page":"e1003645","DOI":"10.1371\/journal.ppat.1003645","article-title":"Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni","volume":"9","author":"Marek","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2024.107887_b0205","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1021\/acs.biochem.9b00786","article-title":"One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity","volume":"58","author":"Zessin","year":"2019","journal-title":"Biochemistry"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:57:16Z","timestamp":1777463836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S0045206824007922"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107887","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107887"}}